1
Ni Ding, Michael N Helmus: Drug release stent coating process. Schneider, Pennie & Edmonds, November 17, 1998: US05837313 (777 worldwide citation)

A method of coating implantable open lattice metallic stent prosthesis is disclosed which includes sequentially applying a plurality of relatively thin outer layers of a coating composition comprising a solvent mixture of uncured polymeric silicone material and crosslinker and finely divided biologi ...


2
Ni Ding, Michael N Helmus: Drug release stent coating. Boston Scientific Corporation, March 19, 2002: US06358556 (461 worldwide citation)

A method of coating implantable open lattice metallic stent prosthesis is disclosed which includes sequentially applying a plurality of relatively thin outer layers of a coating composition comprising a solvent mixture of uncured polymeric silicone material and crosslinker and finely divided biologi ...


3
Dachuan Yang, Joel L Stanslaski, Lixiao Wang, Scott R Smith: Stent coating. SciMed Life Systems, Crompton Seager & Tufte, July 10, 2001: US06258121 (455 worldwide citation)

A stent having a polymeric coating for controllably releasing an included active agent. The polymeric coating includes a blend of a first polymeric material, which if alone, would release the agent at a first, higher rate, and a second polymeric material, which if alone would release the agent at a ...


4
Robert E Fischell, Tim A Fischell: Intra-arterial stent with the capability to inhibit intimal hyperplasia. Medical Innovative Technologies R & D Partnership, October 22, 1991: US05059166 (351 worldwide citation)

Intra-arterial stents are frequently used subsequent to balloon angioplasty to maintain arterial patency. The most frequent cause for failure to maintain patency is the rapid growth of the injured arterial tissue through the openings in the stent, which rapid growth is called "intimal hyperplasia." ...


5
Dachuan Yang, Carmen Jacob, Lixiao Wang: Surface treatment method for stent coating. SciMed Life Systems, Crompton Seager & Tufte, September 19, 2000: US06120847 (243 worldwide citation)

A method is provided for eliminating surface imperfections on a medical device having a drug release coating including a therapeutic substance in a polymeric carrier disposed on at least a portion of the medical device. The medical device is preferably a stent including wire-like members interconnec ...


6
Ding Ni, Helmus Michael N: Drug release stent coating and process. Schneider Usa, April 1, 1998: EP0832655-A2 (231 worldwide citation)

A coating and method for implantable open lattice metallic stent prostheses are disclosed. The coating includes a relatively thin layer of biostable elastomeric material containing an amount of biologically active material particularly heparin, dispersed in the coating in combination with a non-thro ...


7
David R Fischell, Tim A Fischell: Antithrombogenic radioactive coating for an intravascular stent. Iso Stent, March 3, 1998: US05722984 (198 worldwide citation)

Disclosed is a coating material which has both antithrombogenic properties and contains an embedded radioisotope that makes the coating material radioactive As phosphorous 32 is emerging as the preferred isotope for vascular radioisotope stents, and phosphorylcholine has shown promise as an antithro ...


8
Avraham Shekalim, Ascher Shmulewitz: Stent coating device. Labcoat, Finnegan Henderson Farabow Garrett & Dunner, November 11, 2003: US06645547 (179 worldwide citation)

The present invention is a method and device, which is suitable for use in an operating theater just prior to implantation, for selectively applying a medical coating to an implantable medical device, for example a stent. Disclosed is a device for use with a stent deployed on a catheter balloon. The ...


9
Eckhard Alt: Radioactive stent for treating blood vessels to prevent restenosis. Inflow Dynamics, Blank Rome Comisky & McCauley, February 16, 1999: US05871437 (105 worldwide citation)

A non-radioactive metallic stent is coated with a biodegradable or non-biodegradable thin coating of less than about 100 microns in thickness selected to avoid provoking any foreign body reaction. The coating contains a radioactive source of beta emitting properties for irradiation of tissue when th ...


10
Eckhard Alt: Stent with radioactive coating for treating blood vessels to prevent restenosis. InFlow Dynamics, December 12, 2000: US06159142 (87 worldwide citation)

A non-radioactive metallic stent is coated with a biodegradable thin coating of less than about 100 microns in thickness selected to avoid provoking any foreign body reaction. The biodegradable material in the coating disintegrates over time in the presence of body fluid. The coating contains a radi ...